Back to search
FDAFDA · Food and drugs·Recall number D-0150-2020

Amino Acid Injection 50 g/1000 mL (50 mg/mL) 25 g L-Arginine HCl; 25 g L-Lysine HCl, Single Dose Container, Rx Only Nephron 503B outsourcing facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-988-10

Published October 30, 2019 · Recall initiated: October 9, 2019

Summary

FDA records drug Class II recall D-0150-2020, published October 30, 2019 and initiated October 9, 2019. Recalling firm: Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center; Status: Terminated; Reported quantity: 162 bags; Lot: Lots: AA9023A Exp. 10/24/2019; AA9023B Exp. 10/24/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; bags have potential to leak

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
Distributor
Nationwide.
Lot
Lots: AA9023A Exp. 10/24/2019; AA9023B Exp. 10/24/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Amino Acid Injection 50 g/1000 mL (50 mg/mL) 25 g L-Arginine HCl; 25 g L-Lysine HCl, Single Dose Container, Rx Only Nephron 503B outsourcing facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-988-10 recalled?

Yes. FDA published recall D-0150-2020 on October 30, 2019. Reported hazard: Lack of Assurance of Sterility; bags have potential to leak

What should I do if I have this product?

Voluntary: Firm initiated · Letter